Viking Global Investors Portfolio holdings
AUM
$34.6B
1-Year Return
30.14%
This Quarter Return
-2.73%
1 Year Return
+30.14%
3 Year Return
+120.76%
5 Year Return
+143.03%
10 Year Return
+428.26%
AUM
$24.6B
AUM Growth
+$216M
(+0.88%)
Cap. Flow
+$629M
Cap. Flow
% of AUM
2.55%
Top 10 Holdings %
Top 10 Hldgs %
42.53%
Holding
101
New
15
Increased
31
Reduced
21
Closed
21
Top Buys
| 1 |
United Parcel Service
UPS
|
+$900M |
| 2 |
Microsoft
MSFT
|
+$575M |
| 3 |
Amazon
AMZN
|
+$553M |
| 4 |
XYZ
Block, Inc.
XYZ
|
+$545M |
| 5 |
Workday
WDAY
|
+$472M |
Top Sells
| 1 |
Elevance Health
ELV
|
+$628M |
| 2 |
Sherwin-Williams
SHW
|
+$604M |
| 3 |
Intuit
INTU
|
+$483M |
| 4 |
Arista Networks
ANET
|
+$330M |
| 5 |
Philip Morris
PM
|
+$285M |
Sector Composition
| 1 | Healthcare | 28.63% |
| 2 | Technology | 19.74% |
| 3 | Financials | 16.17% |
| 4 | Industrials | 13.83% |
| 5 | Consumer Discretionary | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
CSX Corp
CSX
$60.5B
| $327M | 1.33% |
10,640,828
-2,166,123
| -17% | -$66.6M |
|
27
Everest Group
EG
$14.7B
| $300M | 1.22% |
808,459
-229,723
| -22% | -$85.4M |
|
28
lululemon athletica
LULU
$19B
| $299M | 1.22% |
776,515
-413,079
| -35% | -$159M |
|
29
Valvoline
VVV
$5.14B
| $286M | 1.16% |
8,867,163
+1,184,349
| +15% | +$38.2M |
|
30
Ginkgo Bioworks
DNA
$593M
| $259M | 1.05% |
3,577,128
| – | – |
|
31
Royalty Pharma
RPRX
$15.7B
| $257M | 1.04% |
9,464,201
-386,731
| -4% | -$10.5M |
|
32
Unum
UNM
$12.8B
| $235M | 0.95% |
4,778,110
-493,277
| -9% | -$24.3M |
|
33
EPAM Systems
EPAM
$8.69B
| $235M | 0.95% |
918,497
+153,590
| +20% | +$39.3M |
|
34
FIVE9
FIVN
$2B
| $231M | 0.94% |
3,593,745
+1,424,158
| +66% | +$91.6M |
|
35
Arthur J. Gallagher & Co
AJG
$76.2B
| $218M | 0.89% |
957,820
+135,305
| +16% | +$30.8M |
|
|
KRTX
36
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $191M | 0.78% |
1,131,263
+183,308
| +19% | +$31M |
|
37
Intuitive Surgical
ISRG
$161B
| $187M | 0.76% |
+640,983
| New | +$187M |
|
38
CBRE Group
CBRE
$48.8B
| $185M | 0.75% |
2,504,799
-2,073,297
| -45% | -$153M |
|
39
MetLife
MET
$53.7B
| $185M | 0.75% |
+2,933,356
| New | +$185M |
|
40
Adaptive Biotechnologies
ADPT
$1.92B
| $163M | 0.66% |
29,993,708
| – | – |
|
41
Progressive
PGR
$146B
| $160M | 0.65% |
1,145,322
+748,885
| +189% | +$104M |
|
42
Acadia Healthcare
ACHC
$2.01B
| $159M | 0.64% |
2,255,213
-985,681
| -30% | -$69.3M |
|
|
RYZB
43
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| $147M | 0.6% |
+6,642,700
| New | +$147M |
|
44
Synopsys
SNPS
$79B
| $141M | 0.57% |
308,059
-2,549
| -0.8% | -$1.17M |
|
45
International Flavors & Fragrances
IFF
$16.8B
| $141M | 0.57% |
2,067,060
-1,502,906
| -42% | -$102M |
|
|
INBX
46
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $131M | 0.53% |
7,150,826
+511,627
| +8% | +$9.39M |
|
47
Mastercard
MA
$525B
| $116M | 0.47% |
292,288
-720,437
| -71% | -$285M |
|
48
Colgate-Palmolive
CL
$67.3B
| $101M | 0.41% |
1,424,845
+186,312
| +15% | +$13.2M |
|
49
KBR
KBR
$6.36B
| $91.7M | 0.37% |
1,555,209
+352,002
| +29% | +$20.7M |
|
|
CNH
50
CNH Industrial
CNH
$13.7B
| $81.6M | 0.33% |
6,741,281
+1,975,113
| +41% | +$23.9M |
|